Jalan Raja Ashman Shah (Jalan Hospital)

Fair Park, Ipoh Utara, 30450, Kinta, Perak, Malaysia

Property Transactions

2 subsales grouped by size · 3-Sty Shop →

Median
RM 1,525,000
PSF
RM 319
Price Size
4,800 sqft
3-Sty Shop
RM 1,550,000
Jalan Basco Kepayang 1
4,779 sqft · RM 324 PSF
RM 1,500,000
Jalan Basco Kepayang 1
4,779 sqft · RM 314 PSF
Legend Recent Highest Price Highest PSF

Posts about Jalan Raja Ashman Shah (Jalan Hospital)

What’s happening in Jalan Raja Ashman Shah (Jalan Hospital)?

No posts about Jalan Raja Ashman Shah (Jalan Hospital) yet. Be the first to share what’s happening here.

Market Snapshot

Commercial

RM 1,525,000

RM 319 psf

Median transaction price

Loading map...

JALAN RAJA ASHMAN SHAH (JALAN HOSPITAL), Fair Park, Ipoh Utara, 30450, Kinta, Perak, Malaysia

Jalan Raja Ashman Shah (Jalan Hospital) in Kinta, Perak recorded 2 subsale transactions between 2021 and 2026, with a median price of RM 1.53 million and a median price per square foot (PSF) of RM 319.

This area consists exclusively of commercial properties, with no residential listings recorded.

Price remained flat, and PSF growth was PSF remained flat. The median price is RM 1.53 million, with most transactions falling within a stable range of RM 1.50 million to RM 1.55 million, and a typical market range of RM 1.50 million to RM 1.55 million.

Most transactions involved 3 - 3 1/2 storey shop, with minimal variety in property types.

For price per square foot, the median is RM 319, with most transactions between RM 314 and RM 324. The usual range is RM 209.09 to RM 429.09, showing that most units are priced quite close to each other. With an IQR of RM 220.00 and MAD of RM 5, the PSF demonstrates reasonable consistency across the market.

While the area has shown positive growth trends, price variations suggest a more dynamic market. This presents opportunities for investors comfortable with moderate volatility. Some price volatility exists, making thorough market research essential before transacting. Limited transaction history suggests carefully evaluating comparable sales data.